SEC Form 4/A · accession 0001415889-16-005178
Cocrystal Pharma, Inc. · COCP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Steven D Rubin
Director
Period of report
Mar 15, 2016
Accepted (ET)
Mar 18, 2016 · 5:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412486
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 15, 2016 | P | 39,216 | $0.51 | A | 733,484 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The original Form 4 filed on March 17, 2016 is amended by this Form 4 to correctly reflect the reporting person's amount of securities beneficially owned. No other changes have been made to the original Form 4.